Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of sixth biannual meeting (September 2014)

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

[No Author Info available]

Author keywords

Drug resistance; Elimination; Malaria; Mosquito control; Plasmodium falciparum; Plasmodium vivax; Policy making; Surveillance; WHO

Indexed keywords

ADVISORY COMMITTEE; CONFERENCE PAPER; FEEDBACK SYSTEM; HEALTH CARE POLICY; HUMAN; INSECTICIDE RESISTANCE; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; PARASITE CLEARANCE; PARASITE TRANSMISSION; PLASMODIUM VIVAX; WORLD HEALTH ORGANIZATION; DRUG RESISTANCE; HEALTH SURVEY; MOSQUITO CONTROL; PLASMODIUM FALCIPARUM;

ADVISORY COMMITTEES; DRUG RESISTANCE; HUMANS; MALARIA; MOSQUITO CONTROL; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PUBLIC HEALTH SURVEILLANCE; WORLD HEALTH ORGANIZATION;

EID: 84928113775     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0623-5     Document Type: Conference Paper

References (48)

1. WHO Malaria Policy Advisory Committee and Secretariat. Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations. Malar J. 2012;11:137.
2. WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J. 2012;11:424.
3. WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting. Malar J. 2013;12:213.
4. WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting. Malar J. 2013;12:456.
5. WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2014 meeting. Malar J. 2014;13:253.
6. Malaria Policy Advisory Committee meeting report series home page. http://www.malariajournal.com/series/WHO-recommendations.
7. Malaria Policy Advisory Committee meetings and operational procedures. http://www.who.int/malaria/mpac/operationalprocedures/en/index.html.
8. Malaria Policy Advisory Committee meetings. http://www.who.int/malaria/mpac/mpacmeetings/en/index.html.
9. Update from WHO GMP Director a.i., presented on 10 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sep2014-director-update.pdf
10. WHO guidance note on capacity building in malaria entomology and vector control, September 2013. http://www.who.int/entity/malaria/publications/atoz/who-guidance-cap-building-entomology/en/index.html
11. WHO progress report on implementing UN General Assembly resolution 67/299, April 2014. http://www.who.int/malaria/publications/atoz/report-un-general-assembly/en/
12. Planning meeting for operational research on malaria elimination. Meeting report, May 2014. http://www.who.int/malaria/publications/atoz/operational-research-malaria-elimination/en/
13. Emergence and spread of artemisinin resistance calls for intensified efforts to withdraw oral artemisinin-based monotherapy from the market, May 2014. http://www.who.int/malaria/publications/atoz/policy-brief-withdrawal-of-oral-artemisinin-based-monotherapies/en/
14. From malaria control to malaria elimination: a manual for elimination scenario planning, April 2014. http://www.who.int/malaria/publications/atoz/9789241507028/en/
15. Safety of 8-aminoquinoline antimalarial medicines, May 2014. http://www.who.int/malaria/publications/atoz/9789241506977/en/
16. Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: Round 5 (2013), July 2014. http://www.who.int/malaria/publications/atoz/9789241507554/en/
17. Update on artemisinin resistance - September 2014. http://www.who.int/malaria/publications/atoz/update-artemisinin-resistance-sep2014/en/
18. Biography of Pedro L. Alonso, MD, PhD. http://www.who.int/entity/malaria/news/2014/pedroalonso-bio/en/index.html
19. Summary and recommendations of the Technical Expert Group on Drug Resistance and Containment meeting (28-30 April 2014), presented on10 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sept2014-drug-resistance-containment-teg-presentation.pdf
20. Minutes of the Technical Expert Group Drug Resistance and Containment meeting (28-30 April 2014). http://www.who.int/entity/malaria/mpac/mpac-sept2014-drug-resistance-containment-teg-report.pdf
21. Feasibility of Plasmodium falciparum elimination in the Greater Mekong Subregion: technical, operational and financial challenges, presented on 11 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sep2014-feasibility-elimination-gms-presentation.pdf
22. Control of residual malaria parasite transmission, presented on 10 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sept2014-residual-parasite-transmission-presentation.pdf
23. WHO recommendations for achieving universal coverage with long-lasting insecticidal nets in malaria control, September 2013 (revised March 2014). http://www.who.int/entity/malaria/publications/atoz/who-recommendation-coverage-llin/en/index.html
24. Indoor residual spraying: An operational manual for IRS for malaria transmission, control and elimination, April 2013. http://www.who.int/entity/malaria/publications/atoz/9789241505123/en/index.html
25. WHO interim position statement - the role of larviciding for malaria control in sub-Saharan Africa, April 2012. http://www.who.int/entity/malaria/publications/atoz/larviciding-position
26. Killeen GF. Characterizing, controlling and eliminating residual malaria transmission. Malar J. 2014;13:330. doi:10.1186/1475-2875-13-330. http://www.malariajournal.com/content/13/1/330.
27. Guidance note on the control of residual malaria parasite transmission, September 2014. http://www.who.int/entity/malaria/publications/atoz/guidance-control-residual-transmission/en/index.html
28. Global plan for insecticide resistance management in malaria vectors (GPIRM), May 2012. http://www.who.int/entity/malaria/publications/atoz/gpirm/en/index.html
29. Update on GPIRM implementation: progress, challenges and the way forward, presented on 10 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sept2014-gpirm-implementation-presentation.pdf
30. Update on GPIRM implementation: progress, challenges and the way forward, background paper. http://www.who.int/entity/malaria/mpac/mpac-sept2014-gpirm-implementation-update.pdf
31. Malaria: draft global technical strategy: post-2015, presented on 10 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sept2014-gts-update-presentation.pdf
32. Homepage of the Global Malaria Action Plan (GMAP2). http://www.gmap2.org/english/home
33. nd Global Malaria Action Plan. Process, structure, content and timelines. Update for the Malaria Policy Advisory Committee meeting, presented on 10 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sept2014-rbm-gmap2-presentation.pdf
34. P. vivax technical brief, presented on 10 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sep2014-pvivax-technical-brief.pdf
35. Elimination Field Manual Update, presented on 11 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sep2014-elimination-manual-presentation.pdf
36. Malaria elimination. A field manual for low and moderate endemic countries, April 2007. http://www.who.int/entity/malaria/publications/atoz/9789241596084/en/index.html
37. Proposal for an Evidence Review Group on MDA, MSAT and FSAT, presented on 11 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sept2014-mda-msat-fsat-presentation.pdf
38. Proposal for an Evidence Review Group on MDA, MSAT & FSAT, pre-read for the September 2014 meeting of the Malaria Policy Advisory Committee. http://www.who.int/entity/malaria/mpac/mpac-sept2014-mda-msat-fsat-report.pdf
39. Surveillance, Monitoring and Evaluation Technical Expert Group (SME TEG), presented on 10 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sep2014-sme-teg-presentation.pdf
40. Antimalarial Dosage Recommendation Working Group Meeting (23-24 June 2014), presented on 10 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sep2014-antimalarial-dosage-recommendation-presentation.pdf
41. Updating the WHO Guidelines for the Treatment of Malaria (MTGs), pre-read for the September 2014 meeting of the Malaria Policy Advisory Committee. http://www.who.int/entity/malaria/mpac/mpac-sept2014-mtg-report.pdf
42. Guidelines for the treatment of malaria. Second edition, March 2010. http://www.who.int/entity/malaria/publications/atoz/9789241547925/en/index.html
43. WHO-FIND Malaria RDT Evaluation Programme: Product Testing Round 5, presented on 11 September 2014. http://www.who.int/entity/malaria/mpac/mpac-sept2014-round5-product-testing-presentation.pdf
44. Malaria rapid diagnostic test performance. Summary results of WHO product testing of malaria RDTs: Round 1-5 (2008-2013), July 2014. http://www.who.int/entity/malaria/publications/atoz/9789241507554-summary-eng.pdf
45. WHO Policy recommendation on intermittent preventive treatment during infancy with sulphadoxine-pyrimethamine (IPTi-SP) for Plasmodium falciparum malaria control in Africa, March 2010. http://www.who.int/entity/malaria/publications/atoz/policy-recommendation-IPTi-032010/en/index.html
46. Benn CS, Aaby P. Does IPTi decrease malaria morbidity but not mortality? Lancet. 2012;380:958-60.
47. Chandramohan D, Owusu-Agyei S, Carneiro I, Awine T, Amponsa-Achiano K, Mensah N, et al. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ. 2005;331:727-33.
48. Malaria Policy Advisory Committee (MPAC) September 2014 meeting list of participants. http://www.who.int/entity/malaria/mpac/mpac-sep2014-list-of-participants.pdf